How Aging Affects the Body: Systems and Changes

Biological aging drives measurable, predictable changes across every major organ system — changes that alter how older adults respond to illness, medication, surgery, and stress. Understanding these changes is foundational to geriatric medicine, informing how clinicians assess risk, adjust treatment thresholds, and set realistic goals of care. The National Institute on Aging (NIA), a component of the National Institutes of Health, identifies physiological aging as distinct from disease, though the two interact in ways that complicate clinical decision-making for adults aged 65 and older.

Definition and scope

Age-related physiological change refers to the gradual, progressive decline in organ reserve and homeostatic capacity that occurs in the absence of disease. The term "aging" in a clinical context is defined narrowly by the National Institute on Aging (NIA) as intrinsic biological change, distinguishing it from pathological processes that accelerate or mimic normal decline.

The scope of these changes is broad. The U.S. Census Bureau projects that adults aged 65 and older will represent approximately 21 percent of the total U.S. population by 2030, up from roughly 17 percent in 2020 (U.S. Census Bureau, 2020 Census). As organ reserve diminishes with age, the clinical margin between health and illness narrows — a concept the regulatory context for geriatrics addresses through age-specific prescribing guidelines, fall prevention mandates, and long-term care quality standards.

Age-related change is universal across adults but varies in rate and magnitude by organ system, sex, genetic background, and lifetime exposures including physical activity, diet, smoking, and comorbid disease burden.

How it works

Aging operates through at least four intersecting biological mechanisms, as described in NIA-funded research and summarized in the National Academies of Sciences, Engineering, and Medicine (NASEM) report The Biology of Aging (2022):

  1. Cellular senescence — Cells stop dividing and accumulate in tissues, secreting inflammatory mediators that impair surrounding tissue function. This senescence-associated secretory phenotype (SASP) contributes to chronic low-grade inflammation, sometimes called "inflammaging."
  2. Mitochondrial dysfunction — Energy production capacity declines as mitochondrial DNA sustains damage without full repair, reducing aerobic capacity and increasing oxidative stress in muscle and cardiac tissue.
  3. Reduced stem cell activity — Tissue repair slows as stem cell pools shrink or become less responsive, affecting wound healing, immune reconstitution, and gut epithelial turnover.
  4. Proteostasis failure — Cells lose efficiency in clearing misfolded or damaged proteins, a mechanism implicated in neurodegenerative conditions including Alzheimer's disease.

These mechanisms manifest differently across body systems:

Cardiovascular system: Arterial walls stiffen due to elastin fragmentation and collagen cross-linking, raising systolic blood pressure and increasing cardiac afterload. Maximum heart rate declines at approximately 1 beat per minute per year of age after age 20, reducing peak exercise capacity (American Heart Association, 2023).

Musculoskeletal system: Skeletal muscle mass declines at roughly 1–2 percent per year after age 50 in sedentary adults, a process classified as sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP2). Bone mineral density loss accelerates after age 65, particularly in postmenopausal women, increasing fracture risk.

Renal system: Glomerular filtration rate (GFR) declines at approximately 1 mL/min/year after age 40, reducing the kidney's ability to clear medications and metabolic waste. The NIA notes that serum creatinine may remain stable even as true GFR falls, because muscle mass — the source of creatinine — also declines with age.

Neurological system: Brain volume decreases at roughly 0.5 percent per year in adults over 60, with white matter integrity declining particularly in prefrontal regions governing executive function and processing speed.

Pulmonary system: Forced expiratory volume in one second (FEV1) declines at approximately 30 mL/year after age 35 in nonsmokers, according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) reference standards.

Endocrine and immune systems: Thyroid function remains largely stable in healthy aging, but insulin sensitivity decreases and immune responsiveness — both humoral and cell-mediated — diminishes, a process called immunosenescence.

Common scenarios

Age-related physiological changes create recognizable clinical patterns that geriatric teams encounter across care settings.

Atypical disease presentation is among the most clinically significant. Older adults with myocardial infarction frequently present without chest pain; pneumonia may present as confusion rather than fever or cough. The blunted fever response results from reduced hypothalamic sensitivity and lower baseline temperature, which the NIA identifies as a recognized feature of advanced age.

Polypharmacy and pharmacokinetic alteration arise directly from renal and hepatic aging. A patient aged 75 with a serum creatinine of 1.0 mg/dL may have an estimated GFR below 50 mL/min/1.73m², requiring dose adjustment for renally cleared drugs. The American Geriatrics Society (AGS) Beers Criteria — updated in 2023 — lists over 40 drug classes or drug combinations to avoid or use with caution in older adults specifically because of altered pharmacokinetics.

Falls and fracture risk increase as gait, balance, and muscle strength decline. The Centers for Disease Control and Prevention (CDC) STEADI (Stopping Elderly Accidents, Deaths & Injuries) initiative identifies adults aged 65 and older as experiencing approximately 36 million falls annually in the United States (CDC STEADI, 2023).

Cognitive vulnerability increases because reduced brain reserve lowers the threshold at which physiological stressors — infection, medication change, surgery, dehydration — trigger delirium or expose underlying cognitive decline.

Decision boundaries

Distinguishing normal aging from pathological change requires structured assessment. The comprehensive geriatric assessment framework, endorsed by the British Geriatrics Society and the AGS, uses validated tools to separate expected functional change from treatable disease.

Four key decision boundaries are recognized in geriatric clinical practice:

Normal vs. pathological decline — A GFR of 58 mL/min/1.73m² in an 80-year-old may represent normal aging; the same GFR in a 45-year-old indicates kidney disease. Age-adjusted reference ranges, available through the National Kidney Foundation's CKD-EPI equations (National Kidney Foundation), provide the comparison standard.

Sarcopenia vs. cachexia vs. malnutrition — Sarcopenia is defined by the EWGSOP2 as low muscle strength plus low muscle quantity or quality, with or without low physical performance. Cachexia involves systemic inflammation and involuntary weight loss, while malnutrition reflects inadequate intake or absorption. The distinctions carry different treatment implications — exercise-based intervention dominates for sarcopenia, while disease-targeted therapy is prioritized in cachexia.

Mild cognitive impairment (MCI) vs. normal cognitive aging vs. dementia — The National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria, updated through NIA-Alzheimer's Association 2011 guidelines, distinguish subjective cognitive complaints, objective but functionally intact MCI, and dementia by functional impact thresholds.

Frailty vs. disability — Frailty, defined by Linda Fried's 2001 phenotype model (unintentional weight loss, exhaustion, weakness, slowness, low activity — 3 or more criteria positive), predicts adverse health outcomes independently of disability and comorbidity. Disability refers to loss of specific function, not the underlying vulnerability state. The frailty assessment tools used in geriatrics operationalize this boundary.

Understanding where a patient falls within these boundaries directly shapes the intensity and type of intervention — including whether functional status evaluation or subspecialty referral is warranted.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)